105 related articles for article (PubMed ID: 3381266)
1. Treatment of endogenous uveitis with cyclosporine A.
BenEzra D; Cohen E; Rakotomalala M; de Courten C; Harris W; Chajek T; Friedman G; Matamoros N
Transplant Proc; 1988 Jun; 20(3 Suppl 4):122-7. PubMed ID: 3381266
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of conventional therapy versus cyclosporine A in Behçet's syndrome.
BenEzra D; Cohen E; Chajek T; Friedman G; Pizanti S; de Courten C; Harris W
Transplant Proc; 1988 Jun; 20(3 Suppl 4):136-43. PubMed ID: 3381269
[TBL] [Abstract][Full Text] [Related]
3. Comparison of infliximab versus ciclosporin during the initial 6-month treatment period in Behçet disease.
Yamada Y; Sugita S; Tanaka H; Kamoi K; Kawaguchi T; Mochizuki M
Br J Ophthalmol; 2010 Mar; 94(3):284-8. PubMed ID: 19692382
[TBL] [Abstract][Full Text] [Related]
4. Loss of efficacy during long-term infliximab therapy for sight-threatening childhood uveitis.
Simonini G; Zannin ME; Caputo R; Falcini F; de Martino M; Zulian F; Cimaz R
Rheumatology (Oxford); 2008 Oct; 47(10):1510-4. PubMed ID: 18676502
[TBL] [Abstract][Full Text] [Related]
5. Cyclosporine in Behçet's disease resistant to conventional therapy.
Caspers-Velu LE; Decaux G; Libert J
Ann Ophthalmol; 1989 Mar; 21(3):111-6, 118. PubMed ID: 2735696
[TBL] [Abstract][Full Text] [Related]
6. Infliximab effects compared to conventional therapy in the management of retinal vasculitis in Behçet disease.
Tabbara KF; Al-Hemidan AI
Am J Ophthalmol; 2008 Dec; 146(6):845-50.e1. PubMed ID: 18929351
[TBL] [Abstract][Full Text] [Related]
7. Tacrolimus (FK506) in the treatment of posterior uveitis refractory to cyclosporine.
Sloper CM; Powell RJ; Dua HS
Ophthalmology; 1999 Apr; 106(4):723-8. PubMed ID: 10201592
[TBL] [Abstract][Full Text] [Related]
8. Anti-TNF-alpha therapy in seven patients with Behcet's uveitis: advantages and controversial aspects.
Tognon S; Graziani G; Marcolongo R
Ann N Y Acad Sci; 2007 Sep; 1110():474-84. PubMed ID: 17911463
[TBL] [Abstract][Full Text] [Related]
9. Renal interstitial fibrosis and vascular changes. Occurrence in patients with autoimmune diseases treated with cyclosporine.
Svenson K; Bohman SO; Hällgren R
Arch Intern Med; 1986 Oct; 146(10):2007-10. PubMed ID: 3767545
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporin A in the treatment of posterior uveitis.
Graham EM; Sanders MD; James DG; Hamblin A; Kasp Grochowska E; Dumonde D
Trans Ophthalmol Soc U K (1962); 1985; 104 ( Pt 2)():146-51. PubMed ID: 3857775
[TBL] [Abstract][Full Text] [Related]
11. Long-term efficacy of infliximab in refractory posterior uveitis of Behcet's disease: a 24-month follow-up study.
Niccoli L; Nannini C; Benucci M; Chindamo D; Cassarà E; Salvarani C; Cimino L; Gini G; Lenzetti I; Cantini F
Rheumatology (Oxford); 2007 Jul; 46(7):1161-4. PubMed ID: 17478466
[TBL] [Abstract][Full Text] [Related]
12. Long-term progression, prognosis, and treatment of patients with recurrent ocular manifestations of Reiter's syndrome.
Kiss S; Letko E; Qamruddin S; Baltatzis S; Foster CS
Ophthalmology; 2003 Sep; 110(9):1764-9. PubMed ID: 13129875
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of cyclosporin-a in the treatment of Behçet's disease.
Atmaca LS; Batioğlu F
Ophthalmic Surg; 1994 May; 25(5):321-7. PubMed ID: 8058265
[TBL] [Abstract][Full Text] [Related]
14. Combined fluocinolone acetonide intraocular delivery system insertion, phacoemulsification, and intraocular lens implantation for severe uveitis.
Chieh JJ; Carlson AN; Jaffe GJ
Am J Ophthalmol; 2008 Oct; 146(4):589-594. PubMed ID: 18639220
[TBL] [Abstract][Full Text] [Related]
15. [Effect of intravitreal and orbital floor triamcinolone acetonide injection on intraocular inflammation in patients with active non-infectious uveitis].
Roesel M; Gutfleisch M; Heinz C; Heimes B; Zurek-Imhoff B; Heiligenhaus A
Klin Monbl Augenheilkd; 2009 Feb; 226(2):110-4. PubMed ID: 19206044
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporine therapy for severe sight-threatening uveitis in children and adolescents.
Walton RC; Nussenblatt RB; Whitcup SM
Ophthalmology; 1998 Nov; 105(11):2028-34. PubMed ID: 9818601
[TBL] [Abstract][Full Text] [Related]
17. Uveitis in Behçet disease: an analysis of 880 patients.
Tugal-Tutkun I; Onal S; Altan-Yaycioglu R; Huseyin Altunbas H; Urgancioglu M
Am J Ophthalmol; 2004 Sep; 138(3):373-80. PubMed ID: 15364218
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of Grave's ophthalmopathy with high doses of corticosteroids].
Cirić J; Zarković M; Stojanović M; Pepenezić Z; Randjelović G; Gligorović M; Trbojević B; Drezgić M; Nesović M
Srp Arh Celok Lek; 2000; 128(5-6):179-83. PubMed ID: 11089418
[TBL] [Abstract][Full Text] [Related]
19. [Cyclosporin A in therapy of chronic uveitis].
Klein S; Friedrich R; Fricke B; Illéssy A; Bondartschuk K
Ophthalmologe; 1992 Oct; 89(5):411-5. PubMed ID: 1304223
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease: an open-label trial.
Tugal-Tutkun I; Mudun A; Urgancioglu M; Kamali S; Kasapoglu E; Inanc M; Gül A
Arthritis Rheum; 2005 Aug; 52(8):2478-84. PubMed ID: 16052571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
